In this study, it was shown that RAD18 protects glioma cells from entering TMZ-induced cell death, as the siRNA-mediated knockdown of RAD18 sensitized glioma cells towards TMZ treatment and exogenous overexpression of RAD18 prevented TMZ-induced cell death. Here, RAD18 is linked to central nervous system cancer.